# Spero Therapeutics, Inc.: Form 8-K, filed Jul 17, 2018

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2018-07-17
- Accepted by EDGAR: Jul 17, 2018, 16:31 ET
- Period: 2018-07-17
- Accession: 0001193125-18-219722
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312518219722/d541709d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312518219722/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312518219722/d541709d8k.htm

Filed Jul 17, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-219722. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
